Form D · Other Technology

AIxMed, Inc.

Santa Clara, CA · CIK 0001883385

Offering snapshot reported Apr 15, 2022 · SEC filing

Reported sold
$500K
Offering amount: $700K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 1, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 15, 2022Initial$499,999No comparison1SEC filing
Sep 16, 2021Initial$7,769,973No comparison29SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-442139

Source: Form D, filed Apr 15, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samuel Chen Director, Executive
Tien Jen Liu Director, Executive
Shawn Marcell Director
Victoria Wang Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
2975 Scott Blvd., #110
Santa Clara, CA, 95054